Palobiofarma SL

Cadila Healthcare Ltd. , the flagship firm of India's Zydus Cadila group, has entered the league of companies researching interleukin (IL) therapies through a tie-up with Emeryville, California-base

Corvus Pharmaceuticals Inc. hopes to catch the next wave of the immuno-oncology revolution by developing drugs that can treat patients who are resistant/refractory to PD-1/L1 inhibitors, by blocking

Like some of the other companies that are behind in the immuno-oncology space, Novartis AG is relying on combination treatments to get it back in the game and is hoping that its strength in gene t

Like some of the other companies that are behind in the immuno-oncology space, Novartis AG is relying on combination treatments to get it back in the game and is hoping that its strength in gene t